Smart drug improves survival in older patients with acute myeloid leukemia
Monday, November 12, 2012 - 22:30
in Health & Medicine
A new study has found acute myeloid leukemia (AML) patients given a new type of 'smart drug' in addition to chemotherapy treatment are 22 per cent less likely to relapse and around 13 per cent less likely to die from their disease.